Published in Prostaglandins on May 01, 1973
Evidence for prostaglandin mediated prejunctional control of renal sympathetic transmitter release and vascular tone. Br J Pharmacol (1975) 1.00
Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg (1984) 0.98
Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins. J Clin Invest (1983) 0.88
Bartter's syndrome--the case for a primary potassium-losing tubulopathy: discussion paper. J R Soc Med (1983) 0.88
Angiotensin receptors in bovine umbilical artery and their inhibition by nonsteroidal anti-inflammatory drugs. Br J Pharmacol (1981) 0.85
Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin. Postgrad Med J (1983) 0.79
Haemodynamic responses to angiotensin II in conscious lambs: role of nitric oxide and prostaglandins. Pflugers Arch (2011) 0.78
Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin. Br J Pharmacol (1983) 0.78
Renal function and renal venous prostaglandin concentrations during different stages of experimental renal hypertension in the rat. Br J Pharmacol (1976) 0.77
Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins. Br J Pharmacol (1984) 0.75
The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review. J Natl Med Assoc (1992) 0.75
Acute renal failure caused by nephrotoxins. Environ Health Perspect (1976) 0.75
Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol (1998) 2.85
Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II. Circ Res (1970) 2.23
ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol (1996) 2.23
Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circ Res (1975) 2.17
Selective passage of prostaglandins across the lung. Nature (1969) 1.92
Modification by acetylcholine of the response of rat mesenteric arteries to sympathetic stimulation. Circ Res (1969) 1.81
Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res (1972) 1.68
Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science (1989) 1.67
Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol (2001) 1.58
Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase. Nature (1985) 1.49
20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1998) 1.46
Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature (1976) 1.41
Prostaglandins and the kidney. Circ Res (1973) 1.38
Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs. Circ Res (1977) 1.38
Dependency of renal blood flow on prostaglandin synthesis in the dog. Circ Res (1973) 1.37
Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids. Br J Pharmacol (2007) 1.34
Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol (1992) 1.33
Prostaglandin-like substances appearing in canine renal venous blood during renal ischemia. Their patial characterization by pharmacologic and chromatographic procedures. Circ Res (1970) 1.32
Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science (1991) 1.32
Prostaglandins and renal function. Fed Proc (1974) 1.31
Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol (1993) 1.28
Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther (1998) 1.27
Prostaglandins and the regulation of uterine blood flow in pregnancy. Nature (1974) 1.26
Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J (2001) 1.25
Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res (1976) 1.25
Angiotensin II induces TNF production by the thick ascending limb: functional implications. Am J Physiol (1998) 1.23
Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension (2000) 1.21
Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol (2000) 1.21
Receptor-mediated activation of the heterotrimeric G-protein Gs results in ATP release from erythrocytes. Med Sci Monit (2001) 1.18
Prostaglandin synthesis by bovine mesenteric arteries and veins. Circ Res (1975) 1.17
Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) (2001) 1.16
Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol (1987) 1.16
Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Br J Pharmacol (2004) 1.14
Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J Pharmacol Exp Ther (1992) 1.14
History about the discovery of the renin-angiotensin system. Hypertension (2001) 1.13
Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J Pharmacol Exp Ther (1991) 1.12
12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A (1987) 1.11
Cytochrome P450-derived renal HETEs: storage and release. Kidney Int (1997) 1.09
Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest (1999) 1.08
Prostaglandins--modulation of adrenergic nervous system. Fed Proc (1978) 1.07
Differential effect of noradrenaline and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin E-like substance. Clin Sci (1972) 1.07
Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids. Circ Res (1978) 1.07
Allergic bronchopulmonary aspergillosis--a North American Rarity. Clinical and immunologic characteristics. Am J Med (1969) 1.06
Hyperpolarizing factors. Biochem Pharmacol (1997) 1.06
Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. J Biol Chem (1999) 1.05
Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol (1996) 1.05
Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension (1995) 1.04
Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol (1995) 1.03
Modulation and mediation of the action of the renal kallikrein-kinin system by prostaglandins. Fed Proc (1976) 1.03
The effect of 1,1-dimethyl-4-phenyl-piperazinium on the response of mesenteric arteries to sympathetic nerve stimulation. J Pharm Pharmacol (1969) 1.03
Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res (1975) 1.03
Proceedings: Possible contribution of prostaglandins to genetic hypertension in rats: identification of biochemical lesion. Br J Pharmacol (1975) 1.01
Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem (1993) 1.01
The actions of bradykinin and eledoisin in the canine isolated kidney: relationships to prostaglandins. Clin Sci Mol Med (1975) 1.00
Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. J Clin Invest (1997) 1.00
Metabolism of prostacyclin in blood vessels. J Biol Chem (1978) 1.00
Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclin. Eur J Pharmacol (1979) 1.00
Role of K+ channels in the vasodilator response to bradykinin in the rat heart. Br J Pharmacol (1994) 0.99
Functional interaction of calcium-/calmodulin-dependent protein kinase II and cytosolic phospholipase A(2). J Biol Chem (2001) 0.99
Relaxant responses of rabbit aorta: influence of cytochrome P450 inhibitors. J Pharmacol Exp Ther (1994) 0.99
Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat. Circ Res (1991) 0.99
Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification. J Biol Chem (1980) 0.99
Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure. J Hypertens (1997) 0.98
Renal prostaglandins: possible regulators of the renal actions of pressor hormones. Nature (1970) 0.98
Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins. Prostaglandins (1977) 0.97
Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol (1994) 0.97
Biological activity of the methyl esters of prostaglandin E2 and its (15S)-15-methyl analogue. Eur J Pharmacol (1974) 0.97
Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J Pharmacol Exp Ther (1989) 0.97
Novel renal arachidonate metabolites. Am J Med Sci (1988) 0.97
Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem J (1986) 0.96
Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension (1998) 0.96
A new class of lipid mediators: cytochrome P450 arachidonate metabolites. Thorax (2000) 0.96
Hepatic metabolism of prostacyclin (PGI2) in the rabbit: formation of a potent novel inhibitor of platelet aggregation. Biochem Biophys Res Commun (1980) 0.96
Possible influence of intrarenal generation of kinins on prostaglandin release from the rabbit perfused kidney. Br J Pharmacol (1976) 0.96